Delivery Order SPE2DB20D1051-SPE2DB24FD7QF
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $19,013.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,860,781 units of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract is part of a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,148,082 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has a ceiling value of $4,633.76 and a period of performance through April 3, 2024. This order was issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,739 units of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract, valued at $2,096.01, has an ultimate completion date of April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,763.85 and a period of performance through March 21, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,415,474 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,542.47 and a period of performance ending on April 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $1,719.82 to supply the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- This is a $4,487.28 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,590,966 units of the medication Fluticasone Prop HFA 220 MCG 12GM. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,627,166 units of the pharmaceutical product FLUTICASONE PROP HFA 220 MCG 12GM. The $1,685.25 firm fixed price contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has a May 17, 2024 completion date. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a range of...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7QFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,176,783 units of Fluticasone Propionate HFA 220 MCG 12GM. The contract has a ceiling value of $2,318.50 and a performance period through April 8, 2024. This award is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 7/5/24, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/5/24 |